What is the Market Size for Deep Brain Stimulation ? :
IMARC Group’s latest report, titled “Deep Brain Stimulation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global deep brain stimulation market size reached US$ 1.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.0 Billion by 2028, exhibiting a growth rate (CAGR) of 9.54% during 2023-2028
Deep brain stimulation (DBS) is an innovative surgical procedure used to treat a variety of neurological and movement-related disorders, such as Parkinson’s Disease, epilepsy, dystonia, and obsessive-compulsive disorder (OCD). It involves the implantation of electrodes in strategic regions of the brain to generate electrical signals that aid in controlling abnormal impulses in the brain. It utilizes a pacemaker-like device called a programmable generator, which is placed under the skin in the upper chest of the patient, and is connected to the electrodes through a wire. Additionally, it is thought to block the formation of neurological dysfunction, disrupt disruptive impulses, and promote more effective brain functioning. Moreover, it assists patients in managing tremors, stiffness, and dyskinesias without the need for large amounts of medication.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/deep-brain-stimulation-market/requestsample
Who are the Players in the Deep Brain Stimulation market ? :
The competitive landscape of the industry has also been examined along with the profiles of the key players being
- Boston Scientific
- Medtronic
- St. Jude Medical
- Aleva Neurotherapeutics
- Beijing Pins Medical
- NeuroPace
- Neuro Sigma
Deep Brain Stimulation Market Trends and Development:
The global market is driven by the rising prevalence of motor and neurological disorders among the masses. Along with this, the increasing acceptance of minimally invasive (MI) surgical techniques to reduce medical expenses, minimize post-operative scarring, and shorten hospital stays is contributing to the market. In addition, the development of numerous hospitals, nursing homes, and clinics to provide quality healthcare services to patients across the globe is another factor fuelling the market.
Moreover, the widespread integration of artificial intelligence (AI) and the internet of things (IoT) into DBS systems for robot-assisted implantations and multitarget stimulations is creating a favorable market outlook. Apart from this, the growing awareness of the benefits of DBS, early detection of neurological complications, and the rapidly aging population is further boosting the market.
Key Market Segmentation:
Breakup by Stimulation Type:
- Subthalamic DBS
- Globus Pallidus DBS
- Thalamic DBS
- Pedunculopontine Nucleus DBS
Product:
- Single Channel Deep Brain Stimulator
- Dual Channel Deep Brain Stimulator
by Application:
- Parkinson’s Disease (PD)
- Epilepsy
- Dystonia
- Obsessive Compulsive Disorder (OCD)
- Others
End-User:
- Hospitals
- Ambulatory Surgical Centers
- Neurological Centers
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Report Coverage:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2022 |
| Historical Period | 2017-2022 |
| Forecast Period | 2023-2028 |
| Units | US$ Billion |
| Stimulation Types Covered | Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS |
| Products Covered | Single Channel, Dual Channel |
| Applications Covered | Parkinson’s Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), Others |
| End-Users Covered | Hospitals, Ambulatory Surgical Centers, Neurological Centers, Others |
| Region Covered | Asia Pacific, North America, Europe, Middle East and Africa, Latin America |
| Companies Covered | Boston Scientific, Medtronic, St. Jude Medical, Aleva Neurotherapeutics, Beijing Pins Medical, NeuroPace and Neuro Sigma |
| Customization Scope | 10% Free Customization |
| Report Price and Purchase Option | Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499 |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.coms
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Read More: https://digitechindexing.com/